We say farewell to Nat & Makeba. Nat has joined the discovery analytics team at BlueRock Therapeutics, and Makeba who will be attending the SUNY Upstate Medical University. Best wishes to you in your future endeavors – we will miss you!
Our paper on clinical acquired resistance to KRAS G12C inhibition is now out in Cancer Discovery! This was a fantastic team effort with the Corcoran Lab, MGH Thoracic and GI Oncology groups, led by Nori Tanaka, Jess Lin and Chendi Li. The MGH press release is here.
We say farewell to Aya & Wafa. Aya will be at the University of Tsukuba as a faculty member of medicine and Wafa will be attending Harvard Medical school as a graduate student! Best wishes to you in your future endeavors – we will miss you!
Our paper on mechanisms of resistance crizotinib and lorlatinib in ROS1 fusion-positive lung cancer is now available in Clinical Cancer Research. A true translational team effort!